ArticleScientific reports2019

Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models.

Simon P Langdon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.